Article Details
Retrieved on: 2025-09-22 19:56:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CatalYm, a clinical stage biopharma in cancer and cachexia, announced Clinton Musil as its chief financial officer and chief business officer.
Article found on: www.bioxconomy.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here